ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $505,000 | -37.5% | 18,005 | -42.0% | 0.00% | -33.3% |
| Q4 2020 | $808,000 | -30.1% | 31,067 | -0.1% | 0.00% | -40.0% |
| Q3 2020 | $1,156,000 | -27.5% | 31,092 | 0.0% | 0.01% | -37.5% |
| Q2 2020 | $1,595,000 | +61.6% | 31,092 | -0.7% | 0.01% | +33.3% |
| Q1 2020 | $987,000 | -59.0% | 31,317 | -22.5% | 0.01% | -50.0% |
| Q4 2019 | $2,408,000 | +40.7% | 40,385 | -13.5% | 0.01% | +33.3% |
| Q3 2019 | $1,712,000 | +33.8% | 46,690 | +69.7% | 0.01% | +28.6% |
| Q2 2019 | $1,280,000 | +459.0% | 27,520 | +770.9% | 0.01% | +600.0% |
| Q1 2018 | $229,000 | – | 3,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |